Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-28 Sale | 2026-06-01 4:05 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $16 | $10,864 | 165,443 (Direct) | View |
| 2026-05-15 Sale | 2026-05-19 4:10 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $18.76 | $56,280 | 132,247 (Direct) | View |
| 2026-05-07 Sale | 2026-05-11 4:05 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 18,606 | $24.12 | $448,818 | 168,517 (Direct) | View |
| 2026-05-06 Sale | 2026-05-07 4:18 pm | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 75,063 | $20.17 | $1,513,673 | 178,571 (Direct) | View |
| 2026-05-06 Sale | 2026-05-07 4:16 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 47,000 | $20.19 | $948,722 | 116,423 (Direct) | View |
| 2026-05-05 Sale | 2026-05-07 4:16 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 108,234 | $20.61 | $2,230,367 | 611,427 (Direct) | View |
| 2026-05-06 Sale | 2026-05-07 4:15 pm | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 3,167 | $22.88 | $72,461 | 3,166 (Direct) | View |
| 2026-04-29 Sale | 2026-05-01 4:37 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 16,915 | $13.16 | $222,589 | 423 (Direct) | View |
| 2026-04-06 Sale | 2026-04-08 4:51 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,970 | $18.01 | $71,508 | 214,152 (Direct) | View |
| 2026-04-01 Sale | 2026-04-03 3:14 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 15,959 | $16.96 | $270,593 | 17,338 (Direct) | View |
| 2026-04-01 Sale | 2026-04-03 3:13 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $16 | $10,864 | 151,951 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 4:07 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 25,492 | $16.15 | $411,607 | 367,130 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | Heffernan Michael Thomas Director | 29,500 | $0 | 29,500 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-05-28 Exercise | 2026-06-01 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $8.04 | 165,443 (Direct) | View |
| 2026-05-28 Exercise | 2026-06-01 4:05 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $0 | 165,443 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer | 34,200 | $0 | 36,855 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 39,900 | $0 | 40,323 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 24,300 | $0 | 27,934 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 43,500 | $0 | 47,122 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 100,200 | $0 | 190,314 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $12.65 | 132,247 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:10 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $0 | 132,247 (Direct) | View |
| 2026-05-07 Exercise | 2026-05-11 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 18,606 | $9.88 | 168,517 (Direct) | View |
| 2026-05-07 Exercise | 2026-05-11 4:05 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 18,606 | $0 | 168,517 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:18 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 12,563 | $8.04 | 178,571 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:18 pm | N/A 2034-06-24 | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 75,063 | $0 | 178,571 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:18 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 62,500 | $13.43 | 178,571 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:16 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 47,000 | $8.04 | 116,423 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:16 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 47,000 | $0 | 116,423 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 29,329 | $8.04 | 611,427 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 78,905 | $12.65 | 611,427 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 108,234 | $0 | 611,427 (Direct) | View |
| 2026-04-06 Exercise | 2026-04-08 4:51 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,970 | $12.65 | 214,152 (Direct) | View |
| 2026-04-06 Exercise | 2026-04-08 4:51 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,970 | $0 | 214,152 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 3:13 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $8.04 | 151,951 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 3:13 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $0 | 151,951 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-01 4:05 pm | N/A 2036-03-31 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 1,339 | $12.13 | 1,339 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-01 4:05 pm | N/A 2036-03-31 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 1,370 | $12.13 | 1,370 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:14 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 3,166 | $0 | 9,500 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:12 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director | 3,166 | $0 | 9,500 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:12 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 3,166 | $0 | 9,500 (Direct) | View |
| 2026-03-28 Tax Withholding | 2026-03-31 4:11 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 21,892 | $13.89 | 154,981 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:11 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 64,866 | $0 | 154,981 (Direct) | View |
| 2026-03-28 Tax Withholding | 2026-03-31 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 8,241 | $13.89 | 57,497 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 24,200 | $0 | 57,497 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:09 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 3,166 | $0 | 9,500 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:09 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 3,166 | $0 | 6,333 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 5,992 | $8.04 | 367,130 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 19,500 | $12.65 | 367,130 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 25,492 | $0 | 367,130 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:24 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:23 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:23 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:22 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Boyd Taylor Chief Business Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:22 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:20 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 286,000 | $0 | 286,000 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 4:05 pm | N/A 2035-12-31 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 848 | $14.74 | 848 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 4:05 pm | N/A 2035-12-31 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 1,043 | $14.74 | 1,043 (Direct) | View |